European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Neuroimaging studies suggest there may be beneficial effects of video game playing on attention, visuospatial, and memory abilities.

More than 46 million Americans live in rural communities. On average, rural locales lag behind non-rural communities on every measure of prosperity, from poverty rates to employment opportunities.